Compare ARK Genomic Revolution ETF (ARKG) vs YieldMax AI & Tech Portfolio Option Income ETF (GPTY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs YieldMax AI & Tech Portfolio Option Income ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while YieldMax AI & Tech Portfolio Option Income ETF trades at $44.15. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, YieldMax AI & Tech Portfolio Option Income ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | GPTY | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $50.52 |
52-Week Low | $23.09 | $34.73 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GPTY trades at $44.48, down 1.16% today, with a bullish technical signal driven by moving averages, though oscillators are neutral. The ETF maintains a consistent weekly dividend distribution strategy, as highlighted in recent YieldMax announcements. Support levels are at $44 and $43, with resistance at $46. Recent news emphasizes its focus on AI and tech exposure combined with option-income strategies.
The outlook for GPTY hinges on its ability to balance high yield with capital preservation in the AI and tech sector. Key risks include heavy reliance on semiconductor momentum and potential NAV erosion from aggressive option strategies. Analyst sentiment is mixed, with some praising its yield approach while others caution on concentration risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About YieldMax AI & Tech Portfolio Option Income ETF
GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.
Read more on GPTY →
